Indicazioni per la quantificazione delle componenti monoclonali nel siero

Translated title of the contribution: Recommendations for the quantification of serum monoclonal components (MC)

Arialdo Vernocchi, Alberto Dolci, F. Ceriotti, G. Lippi, G. Merlini, M. S. Graziani, A. Caldini, M. Mussap, P. Natali, G. Patelli, S. Maoggi, G. Righetti, A. Lalli

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The quantification of MC provides a surrogate for monitoring the size of the population of malignant cells in patients affected by plasma cell disease (PCD). Consequently, clinical and laboratory guidelines on diagnosis, risk stratification and monitoring of PCD recommend MC quantification as a key information for patient management. To do that, liquid phase immunochemical determination of IgG, IgA and IgM in serum should not be used, because of the inability of the technique to distinguish between monoclonal and polyclonal immunoglobulins. However, new available immunoassays specifically measuring free light chains, or the "so-called" Hevylite assay, may reliably quantify specific MC. As a general recommendation, MC should be quantified on agarose gel electrophoresis by scanning densitometry or from capillary zone electrophoresis readout only, provided that a high resolution electrophoresis is performed and a low concentration MC obscured by other proteins is not present. For integration of the MC peak on electrophoresis, perpendicular drop method is recommended. MC is a critical "analyte" as the potential analytical pitfalls (detection limit depending on the position of the MC and on the polyclonal background, poor linearity of scanning methods, precision performance) show. Thus, a comprehensive program of IQC of MC quantification should be implemented as well as an EQAS.

Original languageItalian
Pages (from-to)199-207
Number of pages9
JournalBiochimica Clinica
Volume39
Issue number3
Publication statusPublished - 2015

Fingerprint

Plasma Cells
Electrophoresis
Information Management
Agar Gel Electrophoresis
Densitometry
Capillary Electrophoresis
Population Density
Serum
Immunoassay
Immunoglobulin A
Immunoglobulin M
Limit of Detection
Immunoglobulins
Immunoglobulin G
Guidelines
Scanning
Plasmas
Light
Monitoring
Sepharose

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Medical Laboratory Technology

Cite this

Indicazioni per la quantificazione delle componenti monoclonali nel siero. / Vernocchi, Arialdo; Dolci, Alberto; Ceriotti, F.; Lippi, G.; Merlini, G.; Graziani, M. S.; Caldini, A.; Mussap, M.; Natali, P.; Patelli, G.; Maoggi, S.; Righetti, G.; Lalli, A.

In: Biochimica Clinica, Vol. 39, No. 3, 2015, p. 199-207.

Research output: Contribution to journalArticle

Vernocchi, A, Dolci, A, Ceriotti, F, Lippi, G, Merlini, G, Graziani, MS, Caldini, A, Mussap, M, Natali, P, Patelli, G, Maoggi, S, Righetti, G & Lalli, A 2015, 'Indicazioni per la quantificazione delle componenti monoclonali nel siero', Biochimica Clinica, vol. 39, no. 3, pp. 199-207.
Vernocchi, Arialdo ; Dolci, Alberto ; Ceriotti, F. ; Lippi, G. ; Merlini, G. ; Graziani, M. S. ; Caldini, A. ; Mussap, M. ; Natali, P. ; Patelli, G. ; Maoggi, S. ; Righetti, G. ; Lalli, A. / Indicazioni per la quantificazione delle componenti monoclonali nel siero. In: Biochimica Clinica. 2015 ; Vol. 39, No. 3. pp. 199-207.
@article{d4f1ee54cdd14e8bbc2d4439b6d4694e,
title = "Indicazioni per la quantificazione delle componenti monoclonali nel siero",
abstract = "The quantification of MC provides a surrogate for monitoring the size of the population of malignant cells in patients affected by plasma cell disease (PCD). Consequently, clinical and laboratory guidelines on diagnosis, risk stratification and monitoring of PCD recommend MC quantification as a key information for patient management. To do that, liquid phase immunochemical determination of IgG, IgA and IgM in serum should not be used, because of the inability of the technique to distinguish between monoclonal and polyclonal immunoglobulins. However, new available immunoassays specifically measuring free light chains, or the {"}so-called{"} Hevylite assay, may reliably quantify specific MC. As a general recommendation, MC should be quantified on agarose gel electrophoresis by scanning densitometry or from capillary zone electrophoresis readout only, provided that a high resolution electrophoresis is performed and a low concentration MC obscured by other proteins is not present. For integration of the MC peak on electrophoresis, perpendicular drop method is recommended. MC is a critical {"}analyte{"} as the potential analytical pitfalls (detection limit depending on the position of the MC and on the polyclonal background, poor linearity of scanning methods, precision performance) show. Thus, a comprehensive program of IQC of MC quantification should be implemented as well as an EQAS.",
author = "Arialdo Vernocchi and Alberto Dolci and F. Ceriotti and G. Lippi and G. Merlini and Graziani, {M. S.} and A. Caldini and M. Mussap and P. Natali and G. Patelli and S. Maoggi and G. Righetti and A. Lalli",
year = "2015",
language = "Italian",
volume = "39",
pages = "199--207",
journal = "Biochimica Clinica",
issn = "0393-0564",
publisher = "CLAS International",
number = "3",

}

TY - JOUR

T1 - Indicazioni per la quantificazione delle componenti monoclonali nel siero

AU - Vernocchi, Arialdo

AU - Dolci, Alberto

AU - Ceriotti, F.

AU - Lippi, G.

AU - Merlini, G.

AU - Graziani, M. S.

AU - Caldini, A.

AU - Mussap, M.

AU - Natali, P.

AU - Patelli, G.

AU - Maoggi, S.

AU - Righetti, G.

AU - Lalli, A.

PY - 2015

Y1 - 2015

N2 - The quantification of MC provides a surrogate for monitoring the size of the population of malignant cells in patients affected by plasma cell disease (PCD). Consequently, clinical and laboratory guidelines on diagnosis, risk stratification and monitoring of PCD recommend MC quantification as a key information for patient management. To do that, liquid phase immunochemical determination of IgG, IgA and IgM in serum should not be used, because of the inability of the technique to distinguish between monoclonal and polyclonal immunoglobulins. However, new available immunoassays specifically measuring free light chains, or the "so-called" Hevylite assay, may reliably quantify specific MC. As a general recommendation, MC should be quantified on agarose gel electrophoresis by scanning densitometry or from capillary zone electrophoresis readout only, provided that a high resolution electrophoresis is performed and a low concentration MC obscured by other proteins is not present. For integration of the MC peak on electrophoresis, perpendicular drop method is recommended. MC is a critical "analyte" as the potential analytical pitfalls (detection limit depending on the position of the MC and on the polyclonal background, poor linearity of scanning methods, precision performance) show. Thus, a comprehensive program of IQC of MC quantification should be implemented as well as an EQAS.

AB - The quantification of MC provides a surrogate for monitoring the size of the population of malignant cells in patients affected by plasma cell disease (PCD). Consequently, clinical and laboratory guidelines on diagnosis, risk stratification and monitoring of PCD recommend MC quantification as a key information for patient management. To do that, liquid phase immunochemical determination of IgG, IgA and IgM in serum should not be used, because of the inability of the technique to distinguish between monoclonal and polyclonal immunoglobulins. However, new available immunoassays specifically measuring free light chains, or the "so-called" Hevylite assay, may reliably quantify specific MC. As a general recommendation, MC should be quantified on agarose gel electrophoresis by scanning densitometry or from capillary zone electrophoresis readout only, provided that a high resolution electrophoresis is performed and a low concentration MC obscured by other proteins is not present. For integration of the MC peak on electrophoresis, perpendicular drop method is recommended. MC is a critical "analyte" as the potential analytical pitfalls (detection limit depending on the position of the MC and on the polyclonal background, poor linearity of scanning methods, precision performance) show. Thus, a comprehensive program of IQC of MC quantification should be implemented as well as an EQAS.

UR - http://www.scopus.com/inward/record.url?scp=84943257786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943257786&partnerID=8YFLogxK

M3 - Articolo

VL - 39

SP - 199

EP - 207

JO - Biochimica Clinica

JF - Biochimica Clinica

SN - 0393-0564

IS - 3

ER -